A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.


Updates from The Motley Fool

Latest updates on NxStage Medical from Fool.com.


Stock Performance

NXTM vs. S&P 500 | 2 Year Performance
View Interactive NXTM Charts
Sponsored by

Key Data Points

Primary metrics and data points about NxStage Medical.
Current Price: $23.15
Prev Close: $22.94
Open: $23.01
Bid: $22.40
Ask: $25.95
Day's Range: $22.89 - $23.27
52wk Range: $13.49 - $26.07
Volume: 246,010
Avg Vol 574,669
Market Cap: $1.48B
P/E (ttm): -191.17
EPS (ttm): -$0.12
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NxStage Medical.
CAPS Rating 3 out of 5
 
147 Outperform
33 Underperform
CAPS All Stars
 
37 Outperform
9 Underperform

How do you think NxStage Medical will perform against the market?



You pick for NxStage Medical is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jeff Burbank, CEO

97% Approve

Based on 17 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NxStage Medical.

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT